Compare CYN & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYN | BGLC |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | Malaysia |
| Employees | 62 | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 3.8M |
| IPO Year | 2021 | 2019 |
| Metric | CYN | BGLC |
|---|---|---|
| Price | $0.41 | $1.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 192.7K | 8.0K |
| Earning Date | 11-17-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.78 |
| EPS | N/A | ★ N/A |
| Revenue | $368,138.00 | ★ $7,424,911.00 |
| Revenue This Year | $424.72 | N/A |
| Revenue Next Year | $596.26 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.44 | $1.07 |
| 52 Week High | $5.09 | $5.85 |
| Indicator | CYN | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 22.71 | 41.82 |
| Support Level | N/A | $1.12 |
| Resistance Level | $1.76 | $1.39 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 1.36 | 25.12 |
Cyngn Inc is an industrial autonomous vehicle technology company, focused on addressing industrial uses for autonomous vehicles. It develops full-stack autonomous driving software, DriveMod, which is integrated into vehicles manufactured by original equipment manufacturers during the assembly process. The company designs its software to be compatible with a range of sensors and hardware components and integrates it with its own systems to enable autonomous vehicle functionality.
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.